Evidence map›Paper›PMID 24430743›Full record

ArticleMolecular neurobiology2014

Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.

Eun-Joo Shin, Seung Woo Shin, Thuy-Ty Lan Nguyen, Dae Hun Park, Myung-Bok Wie, Choon-Gon Jang, Seung-Yeol Nah, Byung Wook Yang, Sung Kwon Ko, Toshitaka Nabeshima and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Article
  3. Journal of ginseng research · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Role of Microglia in Psychostimulant Addiction.Current neuropharmacology · 2023
    Review
  11. Article
  12. Article
  13. Pharmacological Properties of Ginsenoside Re.Frontiers in pharmacology · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Eun-Joo ShinNeuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, 200-701, Republic of Korea.
Seung Woo Shin
Thuy-Ty Lan Nguyen
Dae Hun Park
Myung-Bok Wie
Choon-Gon Jang
Seung-Yeol Nah
Byung Wook Yang
Sung Kwon Ko
Toshitaka Nabeshima
Hyoung-Chun Kim
Kangwon National University · KRChung-Ang University · KRDongshin University · KRKonkuk University · KRMeijo University · JPSemyung University · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenoside Re, one of the main constituents of Panax ginseng, possesses novel antioxidant and anti-inflammatory properties. However, the pharmacological mechanism of ginsenoside Re in dopaminergic degeneration remains elusive. We suggested that protein kinase C (PKC) δ mediates methamphetamine (MA)-induced dopaminergic toxicity. Treatment with ginsenoside Re significantly attenuated methamphetamine-induced dopaminergic degeneration in vivo by inhibiting impaired enzymatic antioxidant systems, mitochondrial oxidative stress, mitochondrial translocation of protein kinase Cδ, mitochondrial dysfunction, pro-inflammatory microglial activation, and apoptosis. These protective effects were comparable to those observed with genetic inhibition of PKCδ in PKCδ knockout (-/-) mice and with PKCδ antisense oligonucleotides, and ginsenoside Re did not provide any additional protective effects in the presence of PKCδ inhibition. Our results suggest that PKCδ is a critical target for ginsenoside Re-mediated protective activity in response to dopaminergic degeneration induced by MA.

Indexed as

AnimalsDopaminergic NeuronsGinsenosidesMethamphetamineMiceMice, Inbred C57BLMice, TransgenicMicrogliaMitochondriaNerve DegenerationOxidative StressProtein Kinase C-deltaProtein Kinase Inhibitorsginsenoside ReGinsenosidesMethamphetamineProtein Kinase C-deltaProtein Kinase Inhibitors

Identifiers

PMID24430743
OpenAlexW1982644516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.